 Kindred Biosciences, Inc. NASDAQ: KIN, a biopharmaceutical company focused on saving and improving the lives of pets, will release its second quarter 2020 financial results on August 5, 2020, after the market close. The Company will host a conference call at 4:30 p.m. Eastern time1:30 p.m. Pacific time that day. 